📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cubist

1.1 - Company Overview

Cubist Logo

Cubist

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical products focused on the research, development, and commercialization of therapies addressing unmet medical needs in the acute care environment; markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cubist

Cytovale Logo

Cytovale

HQ: United States Website
  • Description: Provider of early detection diagnostic technologies for immune-mediated diseases, including the IntelliSep Test for rapid sepsis identification with results in under 10 minutes to aid emergency department triage, powered by microfluidics, precision imaging, and machine learning to analyze complex biological data and perform detailed cellular analysis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cytovale company profile →
Biotest Pharmaceuticals Logo

Biotest Pharmaceuticals

HQ: United States Website
  • Description: Provider of pharmaceutical and biotherapeutic products utilized in immunology, with innovation in haematology, clinical immunology and intensive care medicine, incorporating innovative technologies and a sharp focus on safety.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biotest Pharmaceuticals company profile →
Revagenix Logo

Revagenix

HQ: United States Website
  • Description: Provider of infectious disease therapeutics, including a late-preclinical broad-spectrum antimicrobial for cUTI, HABP, VABP, neonatal sepsis and BSI; a novel agent to reduce care burden in chronic pulmonary infections; a treatment with a novel mechanism for challenging Gram-negative infections; and an on-hold pipeline of Gram-negative antibacterials that can be activated within 12-18 months.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Revagenix company profile →
Qpex Biopharma Logo

Qpex Biopharma

HQ: United States Website
  • Description: Provider of antibiotic agents addressing critical needs in infectious disease treatment and antimicrobial resistance for inpatient and outpatient care. Portfolio includes QPX7728, an ultra-broad-spectrum beta-lactamase inhibitor; OMNIvance (Xeruborbactam + Meropenem) for gram-negative infections; ORAvance, an oral Xeruborbactam prodrug enhancing oral beta-lactams; and QPX9003, a lipopeptide for MDR gram-negative pathogens.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Qpex Biopharma company profile →
Crucell Logo

Crucell

HQ: The Netherlands Website
  • Description: Provider of global biopharmaceutical vaccine development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Crucell company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cubist

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cubist

2.2 - Growth funds investing in similar companies to Cubist

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cubist

4.2 - Public trading comparable groups for Cubist

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cubist

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cubist

What does Cubist do?

Cubist is a provider of biopharmaceutical products focused on the research, development, and commercialization of therapies addressing unmet medical needs in the acute care environment; markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides.

Who are Cubist's competitors?

Cubist's competitors and similar companies include Cytovale, Biotest Pharmaceuticals, Revagenix, Qpex Biopharma, and Crucell.

Where is Cubist headquartered?

Cubist is headquartered in United States.

How many employees does Cubist have?

Cubist has 1,000 employees 🔒.

When was Cubist founded?

Cubist was founded in 2010 🔒.

What sector and industry vertical is Cubist in?

Cubist is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cubist

Who are the top strategic acquirers in Cubist's sector and industry

Top strategic M&A buyers and acquirers in Cubist's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cubist?

Top strategic M&A buyers groups and sectors for Cubist include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cubist's sector and industry vertical

Which are the top PE firms investing in Cubist's sector and industry vertical?

Top PE firms investing in Cubist's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cubist's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cubist's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cubist's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cubist include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cubist's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cubist?

The key public trading comparables and valuation benchmarks for Cubist include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cubist for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cubist with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cubist's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cubist with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cubist's' sector and industry vertical?

Access recent funding rounds and capital raises in Cubist's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cubist